Due Diligence & Valuation

Meta's $14B Scale AI Deal: The Biggest AI Acqui-Hire in History

Michael Bommarito

A $14.3 Billion Question

Meta is spending $14.3 billion to take a 49% non-voting stake in Scale AI. If you are trying to come up with a cleaner example of a transaction that is not quite an acquisition but also not quite just an investment, good luck. This one has the unmistakable shape of an acqui-hire, except the price tag is doing the heavy lifting.

And that is the real story here.

Scale AI is not being bought in the old-fashioned sense. Meta is not getting full control, and it is not getting a traditional set of governance rights that would make the lawyers smile and the antitrust folks shrug. According to reporting at the time of the deal, Meta is taking non-voting stock and avoiding veto and drag-along rights. That is not how people usually behave when they are casually writing a check this large. It looks more like a carefully engineered structure designed to stay below the line where control becomes obvious and regulatory scrutiny becomes inevitable.

Which raises the obvious question: if this is not control, what is it?

The Deal Structure Matters

The headline number is easy to understand. The structure is not.

A 49% non-voting stake means Meta gets economic exposure without formal control. That matters for board dynamics, customer perception, competitive positioning, and regulation. In plain English: Meta gets a lot of upside, a lot of influence, and just enough distance to say, “No, really, this is different.”

Maybe it is. Maybe it is not. That depends on what you think a deal is supposed to do.

If you are a lawyer, the difference between voting and non-voting rights is not a footnote. It is the footnote. If you are a finance person, the difference between a strategic investment and a disguised acquisition is not semantics; it changes how you think about governance, dilution, control premiums, and risk allocation. If you are a founder, it is the difference between “we found a partner” and “we sold the future, but only some of it.”

And if you are a customer of Scale AI, the question is even simpler: does this company still feel neutral?

That is not a rhetorical question for many enterprise buyers. Scale’s business sits in the middle of AI infrastructure. It helps supply the data, labeling, evaluation, and human feedback needed to build and test models. Those services are valuable precisely because they are supposed to be broadly useful across the market. But when a company like Meta shows up with a check this large, neutrality starts to look expensive.

Why Meta Is Doing This

Meta’s AI strategy has been clear for a while: move fast, spend big, and catch up where it can. It has open-sourced Llama, pushed aggressively on model development, and tried to position itself as a serious frontier AI player. But frontier AI is not just about model weights and benchmark bragging rights. It is about data, evaluation, workflows, and the ugly middle layer where most of the real engineering lives.

Scale is attractive because it is closer to the plumbing than the press release. It sits on the data-labeling and AI operations stack that makes models more reliable. That is where a lot of the hidden leverage is in modern AI. The market loves to talk about model architecture. The market is less enthusiastic about annotation quality, test sets, governance, and the operational machinery that turns a demo into a product.

That machinery is hard to build well. It is also hard to replace quickly.

So Meta is not just buying a company. It is buying time, capability, and likely a lot of hard-won institutional knowledge. It is also buying the CEO. Alexandr Wang is moving to Meta to help lead its AI push, which is why the term “acqui-hire” is not a joke here. It is a concise description of what the deal feels like in practice, even if the legal wrapper says something else.

Valuation, Meet Reality

The deal implies a valuation for Scale of roughly $29 billion. That is the part everyone notices first, because big numbers are fun and because the AI market has made “crazy” feel normal.

But valuation in AI is getting weird in ways that should make people pause.

What exactly is being valued here? Revenue? Talent? Data assets? Customer relationships? Strategic position? The ability to supply the boring but essential infrastructure that frontier models need? The answer is usually “all of the above,” which is another way of saying “good luck separating the components.”

That is where due diligence matters. Not the ceremonial version, either. Real diligence. The kind that asks:

  • Who owns the underlying data rights?
  • What are the customer concentration risks?
  • How sticky is the infrastructure?
  • What happens to the business if a major client gets nervous?
  • Are the governance and control rights aligned with the story being sold to the market?
  • Is the headline valuation reflecting operating value, strategic value, or pure scarcity value?

Those are not theoretical questions. In a transaction like this, they are the deal.

If you are valuing an AI infrastructure company, you cannot just look at ARR multiples and call it a day. You need to understand the AI footprint of the business: how deeply the company is embedded in model training and evaluation, what parts of the stack are differentiated, what parts are commoditizing, and whether the economics depend on a few hyperscale relationships that can change overnight.

That is especially true when the buyer is also a major industry participant. Strategic money is not the same as passive money. The price may be the same. The risk profile is not.

The Control Premium That Isn’t

There is also a practical governance lesson here: minority investments can still behave like control transactions without looking like them on paper.

That is not automatically bad. Sometimes it is rational. Sometimes it is the only workable structure. Sometimes it is just what happens when the market is moving faster than the old M&A playbook can keep up.

But if you are sitting on the sell side, or advising the board, or underwriting the capital structure, you should be honest about what is happening. The deal may say “non-voting stake,” but the market hears “strategic realignment.” The customers may hear “dependency.” Competitors may hear “arms race.” Regulators may hear “nice try.”

That is why transactions like this benefit from disciplined technology due diligence and valuation work before the press release. You want to know whether the story holds up when you strip away the charisma, the urgency, and the AI glitter. You want to know whether the company is being priced as a software platform, a data utility, or a strategic choke point. Those are very different businesses.

What To Take Away

Meta’s Scale AI deal is a reminder that AI transactions are getting structurally more creative and economically more aggressive at the same time. The market is no longer just paying for software. It is paying for data, human feedback loops, model-adjacent infrastructure, and the people who know how to run them.

That makes valuation harder, not easier.

It also makes diligence more important than ever. If you are looking at an AI company today, you need to understand not just what it sells, but what it touches, who depends on it, and what happens when a giant platform decides the asset is strategically necessary. That is where the real risk sits. Not in the slide deck. In the dependencies.

And when the deal structure looks like a minority investment but the economics look like an acquisition, it is worth asking the uncomfortable question: is this the future of M&A, or just the part where everyone pretends not to notice what the deal really is?

For the underlying reporting, see AP’s coverage, Axios’s breakdown of the non-voting structure, and Scale’s announcement page.

Related posts

Want to discuss this topic?

We'll give you a straight answer — not a sales pitch.